INS and chronic kidney disease: Previous studies comparing glucose-related outcomes between insulin- and noninsulin-treated patients with diabetes mellitus and CKD found a mean HbA1c of 7.5% (58 mmol/mol) among insulin-treated patients compared to 6.7% (50 mmol/mol) among those who were noninsulin-treated [13].